The Gynecologic Oncology Group experience in ovarian cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)31481-2 ◽

1999 ◽

Vol 10 ◽

pp. S29-S34 ◽

Author(s):

W.P. McGuire ◽

M.F. Brady ◽

R.F. Ozols

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Group Experience

Download Full-text

Localized ovarian cancer in the elderly: The gynecologic oncology group experience

Cancer ◽

10.1002/cncr.2820710217 ◽

2010 ◽

Vol 71 (S2) ◽

pp. 601-605 ◽

Author(s):

Robert C. Young ◽

Mark F. Brady ◽

Leslie A. Walton ◽

Howard D. Homesley ◽

Hervy E. Averette ◽

...

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

The Elderly ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Group Experience

Download Full-text

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.08.004 ◽

2017 ◽

Vol 147 (2) ◽

pp. 243-249 ◽

Author(s):

Kate E. Oliver ◽

William E. Brady ◽

Michael Birrer ◽

David M. Gershenson ◽

Gini Fleming ◽

...

Keyword(s):

Ovarian Cancer ◽

Clear Cell Carcinoma ◽

Gynecologic Oncology ◽

Progression Free Survival ◽

Serous Carcinoma ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Free Survival ◽

Group Experience

Download Full-text

Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group

Journal of Gynecologic Oncology ◽

10.3802/jgo.2020.31.e5 ◽

2020 ◽

Vol 31 (1) ◽

Author(s):

Chyong-Huey Lai ◽

Elizabeth Vallikad ◽

Hao Lin ◽

Lan-Yan Yang ◽

Shih-Ming Jung ◽

...

Keyword(s):

Ovarian Cancer ◽

Liposomal Doxorubicin ◽

Gynecologic Oncology ◽

Randomized Study ◽

Advanced Ovarian Cancer ◽

Pegylated Liposomal Doxorubicin ◽

Gynecologic Oncology Group ◽

Download Full-text

A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial

Journal of Gynecologic Oncology ◽

10.3802/jgo.2022.33.e12 ◽

2022 ◽

Vol 33 ◽

Author(s):

Junsik Park ◽

Myong Cheol Lim ◽

Jae-Kwan Lee ◽

Dae Hoon Jeong ◽

Se Ik Kim ◽

...

Keyword(s):

Ovarian Cancer ◽

Maintenance Therapy ◽

Phase Ii Study ◽

Parp Inhibitor ◽

Gynecologic Oncology ◽

Recurrent Ovarian Cancer ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Platinum Sensitive ◽

Previously Treated

Download Full-text

Shaping the standard of care in ovarian cancer management: A review of Gynecologic Oncology Group (GOG)/NRG oncology clinical trials of the past twenty years

Gynecologic Oncology ◽

10.1016/j.ygyno.2019.02.020 ◽

2019 ◽

Vol 153 (3) ◽

pp. 479-486 ◽

Author(s):

Paul A. DiSilvestro

Keyword(s):

Ovarian Cancer ◽

Clinical Trials ◽

Gynecologic Oncology ◽

Standard Of Care ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Cancer Management ◽

The Past ◽

Oncology Clinical Trials

Download Full-text

Translational research in the Gynecologic Oncology Group: Evaluation of ovarian cancer markers, profiles, and novel therapies

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.01.048 ◽

2010 ◽

Vol 117 (3) ◽

pp. 429-439 ◽

Author(s):

Kathleen M. Darcy ◽

Michael J. Birrer

Keyword(s):

Ovarian Cancer ◽

Translational Research ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Novel Therapies ◽

Oncology Group ◽

Cancer Markers ◽

Group Evaluation

Download Full-text

Maspin expression in epithelial ovarian cancer and associations with poor prognosis: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.02.014 ◽

2006 ◽

Vol 101 (3) ◽

pp. 390-397 ◽

Author(s):

Angeles Alvarez Secord ◽

Paula S. Lee ◽

Kathleen M. Darcy ◽

Laura J. Havrilesky ◽

Lisa A. Grace ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Poor Prognosis ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Maspin Expression

Download Full-text

Clinical trials of newer regimens for treating ovarian cancer: the rationale for Gynecologic Oncology Group Protocol GOG 182-ICON5

Gynecologic Oncology ◽

10.1016/s0090-8258(03)00337-8 ◽

2003 ◽

Vol 90 (2) ◽

pp. S1-S7 ◽

Author(s):

Larry J Copeland ◽

Michael Bookman ◽

Edward Trimble

Keyword(s):

Ovarian Cancer ◽

Clinical Trials ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Download Full-text

Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)

10.1186/s12885-019-5514-7 ◽

2019 ◽

Vol 19 (1) ◽

Author(s):

Young Shin Chung ◽

Sang-Yoon Park ◽

Jung-Yun Lee ◽

Jeong-Yeol Park ◽

Jeong-Won Lee ◽

...

Keyword(s):

Ovarian Cancer ◽

Neoadjuvant Chemotherapy ◽

Gynecologic Oncology ◽

Serous Carcinoma ◽

Gynecologic Oncology Group ◽

Advanced Stage ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218

Gynecologic Oncology ◽

10.1016/j.ygyno.2019.07.020 ◽

2019 ◽

Vol 155 (1) ◽

pp. 69-74 ◽

Author(s):

K.N. Slaughter Wade ◽

M.F. Brady ◽

T. Thai ◽

Y. Wang ◽

B. Zheng ◽

...

Keyword(s):

Ovarian Cancer ◽

Data Analysis ◽

Epithelial Ovarian Cancer ◽

Gynecologic Oncology ◽

Prognostic Biomarkers ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Download Full-text